Kogo M - Search Results

1

EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma.

Kaneko K, Kumekawa Y, Makino R, Nozawa H, Hirayama Y, Kogo M, Konishi K, Katagiri A, Kubota Y, Muramoto T, Kushima M, Ohmori T, Oyama T, Kagawa N, Ohtsu A, Imawari M. Kaneko K, et al. Among authors: kogo m. Front Biosci (Landmark Ed). 2010 Jan 1;15(1):65-72. doi: 10.2741/3607. Front Biosci (Landmark Ed). 2010. PMID: 20036807 Free article.

2

Prognostic factors of primary biliary cirrhosis detected by health screening.

Yoneyama K, Yamazaki M, Kogo M, Kiuchi Y, Shibata M, Imawari M. Yoneyama K, et al. Among authors: kogo m. Minerva Gastroenterol Dietol. 2006 Mar;52(1):97-105. Minerva Gastroenterol Dietol. 2006. PMID: 16554710

3

Evaluation of paraumbilical vein as a prognostic index of severe liver cirrhotic patients with portal-systemic shunts.

Kogo M, Nebashi Y, Taniguchi H, Yoneyama K, Imawari M, Kiuchi Y. Kogo M, et al. Minerva Gastroenterol Dietol. 2006 Dec;52(4):371-8. Minerva Gastroenterol Dietol. 2006. PMID: 17108867

4

[Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].

Tomura K, Kogo M, Inoue T, Kaneko K, Imawari M, Yoneyama K, Kiuchi Y. Tomura K, et al. Among authors: kogo m. Gan To Kagaku Ryoho. 2007 Nov;34(11):1807-13. Gan To Kagaku Ryoho. 2007. PMID: 18030014 Japanese.

5

Bleeding index after the first course of endoscopic treatment for esophageal varices in liver cirrhotic patients with and without hepatocellular carcinoma.

Kogo M, Sato N, Yoneyama K, Imawari M, Kiuchi Y. Kogo M, et al. Hepatogastroenterology. 2007 Oct-Nov;54(79):2049-54. Hepatogastroenterology. 2007. PMID: 18251158

6

Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer.

Kogo M, Suzuki A, Kaneko K, Yoneyama K, Imawari M, Kiuchi Y. Kogo M, et al. Dig Dis Sci. 2008 Sep;53(9):2415-21. doi: 10.1007/s10620-007-0149-y. Epub 2008 Feb 8. Dig Dis Sci. 2008. PMID: 18256935

7

Concordant DNA methylation in synchronous colorectal carcinomas.

Konishi K, Shen L, Jelinek J, Watanabe Y, Ahmed S, Kaneko K, Kogo M, Takano T, Imawari M, Hamilton SR, Issa JP. Konishi K, et al. Among authors: kogo m. Cancer Prev Res (Phila). 2009 Sep;2(9):814-22. doi: 10.1158/1940-6207.CAPR-09-0054. Epub 2009 Sep 8. Cancer Prev Res (Phila). 2009. PMID: 19737982 Free PMC article.

8

[Cost-effectiveness analysis of chemotherapy with GEM or S-1 for patients with non-resectable pancreatic cancer].

Kurihara T, Kobayashi M, Kogo M, Yoneyama K, Ito N, Sunaga T, Konishi K, Imawari M, Tobe T, Kiuchi Y. Kurihara T, et al. Among authors: kogo m. Gan To Kagaku Ryoho. 2010 Apr;37(4):659-64. Gan To Kagaku Ryoho. 2010. PMID: 20414022 Japanese.

9

TS gene tandem repeats in esophageal cancer patients receiving chemoradiotherapy.

Kaneko K, Nagai M, Murakami Y, Kogo M, Oyama T, Kojima T, Ohtsu A, Imawari M. Kaneko K, et al. Among authors: kogo m. Front Biosci (Landmark Ed). 2011 Jan 1;16(3):1036-43. doi: 10.2741/3733. Front Biosci (Landmark Ed). 2011. PMID: 21196216 Free article.

10

Analysis of the risk factors for myelosuppression after chemoradiotherapy involving 5-fluorouracil and platinum for patients with esophageal cancer.

Kogo M, Watahiki M, Sunaga T, Kaneko K, Yoneyama K, Imawari M, Kiuchi Y. Kogo M, et al. Hepatogastroenterology. 2011 May-Jun;58(107-108):802-8. Hepatogastroenterology. 2011. PMID: 21830394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page